Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, distinguishing it from approved agents such as semaglutide or tirzepatide
Lipotropic Function: Key Differences Semaglutide operates as a glucagon-like peptide-1 (GLP-1) receptor agonist, activating receptors throughout the brain, pancreas, and gastrointestinal tract
This medication works in the following ways: Increase insulin secretion Tirzepatide binds with the GLP-1 receptors in the pancreas and enhances insulin secretion in a glucose-dependent manner (only when the glucose level is high), which reduces the spikes in blood sugar level after a meal and also lowers the risk of hypoglycemia
This year we started offering Exosomes and Peptides at our Exosome Clinic Peptide Clinic be Our team of medical staff includes some of the most experienced medical professionals in the industry
Quick Comparison Table For a straightforward overview, this table highlights the main points of comparison between tirzepatide and semaglutide
personalized genetic guidance can enhance those results over the long term